Author

Yang Shi

Wayne State UniversityORCID 0000-0002-3993-2599Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Yang Shi7 papers · Boston Children's Hospital

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Research Focus:gene regulatory network inference· 2 Organism:mouse· 2 Approach:statistical model· 2 Research Focus:cancer & tumor microenvironment· 1

Frequent Co-Authors

Allan M. JohanseniD· 2 shared Amro AboukameeliD· 2 shared Bassel F. El‐RayesiD· 2 shared Boris PascheiD· 2 shared Eliza Wright BealiD· 2 shared Gregory E. DysoniD· 2 shared Herbert R. CheniD· 2 shared Hugo JimeneziD· 2 shared

Activity by Year

2023-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Allan M. JohansenORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologyInternational Journal of Biological SciencesPeer-reviewedSep 3, 2026

Genomic and Transcriptomic Landscapes of MEN1-Wild-Type Low-Grade Metastatic Pancreatic NETs Uncover Key Oncogenic Drivers and Targetable Pathways

Md. Hafiz Uddin, Zaid K Mahdi, Irfana Muqbil…·Asfar S. Azmi

This study identifies key oncogenic pathways and targetable genes in MEN1-wild-type low-grade pancreatic NETs that drive metastasis, offering a therapeutic strategy based on pathway intensity rather than mutation count.

DOI 10.7150/ijbs.134269

humanwhole-exome sequencing

𝕏 PostBluesky

Cancer BiologybioRxivPreprintNov 21, 2025

Co-targeting KRAS and Exportin1 as an effective therapeutic strategy for KRASG12D mutant pancreatic ductal adenocarcinoma

Husain Yar Khan, Mohammed Najeeb Al Hallak, Amro Aboukameel…·Asfar Sohail Azmi

This paper shows that combining Eltanexor and MRTX1133 improves efficacy in KRASG12D mutant PDAC by overcoming resistance and reducing tumor growth.

DOI 10.1101/2025.11.21.689857

𝕏 PostBluesky

NeuroscienceCellsPeer-reviewedSep 3, 2023

MicroRNA-375 is induced during astrocyte-to-neuron reprogramming and promotes survival of reprogrammed neurons when overexpressed

Xuanyu Chen, Ivan Sokirniy, Xin Wang…·Hedong Li

This study identifies miR-375 as a factor that enhances astrocyte-to-neuron reprogramming by promoting cell survival during the process.

9 citations

𝕏 PostBluesky